"नये भारत का नया Tender Portal"
Gem Bids For Acyclovir Tablets V2 Q2, Mycophenolate Mofetil Tablet Q2 V2 Q2, Donepezil Tablet Q2, Hydrochlorothiazide Tablet Q2 V2 Q2, Digoxin Tablet Q2, Diltiazem Tablet Q2 Tablet Q2, Clozapine Tablet Q2, Flunarizine Tablet Q2 % % % % 3 3 0 0 /Minimum Averageannual Turnover Of The Bidder For 3 Years5 Lakh S // 56 56 % %/Years Of Pastexperience Required For Same/Similar Service2 Year S 0 0 % % 9 :9 : / Mse Exemption For Yearsof Experience And Turnoveryes | Complete& % & % 0 0 % % 9 9 / Startupexemption For Years Of Experience And Turnoveryes | Complete ; ; & & /Document Required From Sellerexperience Criteria, Bidder Turnover, Certificate Requested In Atc, Oem Authorizationcertificate*In Case Any Bidder Is Seeking Exemption From Experience / Turnover Criteria, Thesupporting Documents To Prove His Eligibility For Exemption Must Be Uploaded Forevaluation By The Buyer ? ? @ @ A A & ? & ? B B ? ? A A D D? ? % % /Do You Want To Showdocuments Uploaded By Bidders To All Bidders Participated In Bid?Yes Documents Submitted As Part Of A Clarification Or Representation During Thetender/Bid Process Will Also Be Displayed To Other Participated Bidders After Log In & & H H I I /Minimum Number Of Bids Required To Disable Automatic Bidextension1a ?A ? I I, , 5 5 -- / / Number Ofdays For Which Bid Would Be Auto--Extended7 & & / Bid Document1 / 70 B B A A A A / / Number Of Autoextension Count1 O %O % A; A; A A /Bid To Ra Enabledyeso %O % P P /Ra Quali Cation Ruleh1-Highest Priced Bid Elimination 9 9 /Type Of Bidtwo Packet Bid9 9 R R /Primary Product Categoryacyclovir Tablets V2 S S & U & U /Time Allowedfor Technical Clarifications During Technical Evaluation4 Days 6 6 H H V V 6 6 9 9 / % % B ? B ?@ @ /Inspection Required By Empanelled Inspection Authority /Agencies Pre-Registered With Gemno S S V V /Evaluation Methoditem Wise Evaluation/ X & X & /Arbitration Clauseno /Mediation Clauseno //Bid Details /Emd Detail D /Advisory Bankstate Bank Of Indiaschedule 1 /Emd Amount In Inr1656schedule 2 /Emd Amount In Inr5004schedule 3 /Emd Amount In Inr2923schedule 4 /Emd Amount In Inr252schedule 5 /Emd Amount In Inr25schedule 6 /Emd Amount In Inr2680schedule 7 /Emd Amount In Inr525schedule 8 /Emd Amount In Inr360schedule 9 /Emd Amount In Inr540schedule 10 /Emd Amount In Inr7200schedule 11 /Emd Amount In Inr6204schedule 12 /Emd Amount In Inr498schedule 13 /Emd Amount In Inr468 /Epbg Detail2 / 70 D /Advisory Bankstate Bank Of India 9 %/Epbg Percentage%5.00 H /Duration Of Epbg Required Months.6A. 0 % & 9& % & % 9 D \ O ? /Emd Exemption: The Bidder Seeking Emd Exemption, Must Submit The Valid Supportingdocument For The Relevant Category As Per Gem Gtc With The Bid. Under Mse Category, Only Manufacturers For Goods And Service Providers For Services Are Eligible Forexemption From Emd. Traders Are Excluded From The Purview Of This Policy.B. The Emd Amount Will Be Applicable For Each Schedule/Group Selected During Bid Creation.C. , , 6 B A / Emd & Performance Securityshould Be In Favour Of Bene Ciary, Wherever It Is Applicable. /Beneficiary : Ddodirectorate Of Health Services, Health Department Andaman & Nicobar, N/A, Senior Accounts Officer A / Bid Splitting Not Applied. /Mse Purchase Preference /Mse Purchase Preferenceno /Mii Purchase Preference /Mii Purchase Preferenceno1. If The Bidder Is A Micro Or Small Enterprise As Per Latest Orders Issued By Ministry Of Msme, The Bidder Shall Be Exempted From The Eligibility Criteria Of Experiencecriteria As Defined Above Subject To Meeting Of Quality And Technical Specifications. The Bidder Seeking Exemption From Experience Criteria, Shall Upload Thesupporting Documents To Prove His Eligibility For Exemption.2. If The Bidder Is A Micro Or Small Enterprise Mse As Per Latest Orders Issued By Ministry Of Msme, The Bidder Shall Be Exempted From The Eligibility Criteria Of Bidderturnover As Defined Above Subject To Meeting Of Quality And Technical Specifications. If The Bidder Itself Is Mse Oem Of The Offered Products, It Would Be Exempted Fromthe Oem Average Turnover Criteria Also Subject To Meeting Of Quality And Technical Specifications. The Bidder Seeking Exemption From Turnover, Shall Upload Thesupporting Documents To Prove His Eligibility For Exemption.3. If The Bidder Is A Dpiit Registered Startup, The Bidder Shall Be Exempted From The The Eligibility Criteria Of Experience Criteria As Defined Above Subject To Theirmeeting Of Quality And Technical Specifications. The Bidder Seeking Exemption From Experience Criteria, Shall Upload The Supporting Documents To Prove His Eligibilityfor Exemption.4. If The Bidder Is A Dpiit Registered Startup, The Bidder Shall Be Exempted From The The Eligibility Criteria Of Bidder Turnover As Defined Above Subject To Their Meetingof Quality And Technical Specifications. If The Bidder Is Dpiit Registered Oem Of The Offered Products, It Would Be Exempted From The Oem Average Turnover Criteriaalso Subject To Meeting Of Quality And Technical Specifications. The Bidder Seeking Exemption From Turnover Shall Upload The Supporting Documents To Prove Hiseligibility For Exemption. 5. The Minimum Average Annual Financial Turnover Of The Bidder During The Last Three Years, Ending On 31St March Of The Previous Financial Year, Should Be As Indicatedabove In The Bid Document. Documentary Evidence In The Form Of Certified Audited Balance Sheets Of Relevant Periods Or A Certificate From The Chartered Accountant /Cost Accountant Indicating The Turnover Details For The Relevant Period Shall Be Uploaded With The Bid. In Case The Date Of Constitution / Incorporation Of The Bidder Is Lessthan 3-Year-Old, The Average Turnover In Respect Of The Completed Financial Years After The Date Of Constitution Shall Be Taken Into Account For This Criteria. 6. Experience Criteria: In Respect Of The Filter Applied For Experience Criteria, The Bidder Or Its Oem Of The Product Offered In The Bid Themselves Or Through Resellersshould Have Regularly, Manufactured And Supplied Same Or
Supply Of Drug And Medicine -Ketamine Inj Ip 50 Mg/Ml 8, Diclofenac Sodium Injection Ip 25 Mg/ Ml Im/Iv Use 19, Paracetamol Tab Ip 500 Mg 28, Paracetamol Inj. 150Mg/Ml 29, Adrenaline Injection Ip 1Mg/Ml Im/Iv Use 34, Promethazine Syrup Ip 5Mg/5Ml, Promethazine Injection Ip 25Mg/Ml, Amoxycillin And Potassium Clavulanate Tablets Ip 500 Mg + 125 Mg 70, Amoxycillin Cap Ip 500Mg 72, Amphotericin B Injection Ip 50 Mg, Cefixime Tablets Ip 200 Mg, Cefoperazone And Sulbactum For Inj Cefoperazone Sodium Eq.To Cefoperazone 1Gm And Sulbactum Sodium Eq. To Sulbactum 0.5Gmim/Iv Use 86, Cefotaxime Injection Ip 1Gm , Cephalexin Cap Ip 500 Mg 97, Ciprofloxacin Tablets Ip 250 Mg Film Coated , Ciprofloxacin Tablets Ip 500 Mg Film Coated , Clotrimazole Vaginal Tablets Ip 500Mg, Doxycycline Capsules Ip 100 Mg, Metronidazole Benzoate Oral Suspension Ip 100 Mg Of Base/5Ml, Methotrexate Tablets Ip 2.5 Mg, Deferiprone Capsules 250 Mg, Lisinopril Tablets Ip 5 Mg, Acyclovir Cream 5% 213, Ointment Containing : Lidocaine Ip 3%, Zinc Oxide Ip 5%, Hydrocortisone Ip 0.25%, Allantoin Ip 0.5%, Povidone Iodine Ointment 5%, Acetazolamide Tablets Ip 250Mg, Frusemide Tablets Ip 40 Mg., Furosemide Injection Ip 10Mg/Ml Im & Iv Use, Domperidone Suspension Ip 5Mg/5Ml, Ranitidine Tablets Ip 150Mg Film Coated, Methylergometrine Injection Ip 0.2Mg/Ml, Olanzapine Tab Ip 5 Mg 360, Risperidone Tablets Ip 2Mg 361, Aminophylline Injection Ip 25 Mg/Ml, Budesonide Nebulizer Suspension Bp 0.25Mg/Ml , Theophylline Tablet Ip 400Mg Sustained Release/ Controlled Release Theophylline Prolonged Released Tablet Ip 376, Ascorbic Acid Tablets Ip 500 Mg, Water For Inj Ip 404, Ampicillin Capsules Ip 500 Mg, Cloxacillin Sodium Injection Ip 500 Mg, Flurbiprofen Sodium Ophthalmic Solution Ip 0.03% W/V, Zinc Sulphate Dispersible Tablets Ip Elemental Zinc 10 Mg, Ibuprofen Oral Suspension Bp/Usp 100 Mg/ 5 Ml, Brimonidine Tartrate & Timolol Maleate Eye Drops 0.15% + 0.5% 487, Anticold Syrup Each 5 Ml Contains Phenylephrine Hydrochloride 2.5Mg, Chlorpheniramine Maleate 1 Mg, And Paracetamol 125 Mg , Cefepime Injection Ip 500 Mg, Cefixime Oral Suspension Ip 25 Mg/ Ml Paediatric Drops , Levofloxacin Tablets Ip 250 Mg, Betahistine Tablets Ip 8 Mg, Adenosine Injection Ip 6 Mg/2Ml 547, Atorvastatin Tablets Ip 40 Mg , Povidone Iodine Ointment Usp 5%, Neomycin, Polymixin B And Hydrocortisone Ear Drops Neomycin Sulphate 3400 Iu, Polymixin B Sulphate 10000 Iu, And Hydrocortisone 10 Mg Per Ml Neomycin And Polymixin B Sulfate And Hydrocortisone Otic Solution Usp , Gliclazide And Metformin Tablets Gliclazide 80 Mg And Metformin Hydrochloride 500 Mg, Ipratropium Powder For Inhalation Ip 40 Mcg 618, Act Kit Containing 3 Tablets Of Artesunate100 Mg Each And 1 Tablet Of Sulphadoxine And Pyrimethamine750mg+37.5Mg, Inj Piperacillin 2 Gm + Tazobactom 250Mg Ip, Inj. Ceftriaxone 1 Gm + Tazobactum 125 Mg , Inj Meropenem Ip 250 Mg, Mycophenolate Mofetil Capsule/Tablets Ip 250 Mg Each Capsule/Tablets Conatin Mycophenolate Mofetil Ip 250 Mg 738, 3Rd Generation Recombinant F Viii 1000 Iu With Diluent 750, Olopatadine Hydrochloride Ophthalmic Solution 0.1% W/V Ip E/D 5Ml Size, Ointment Mupirocin Ip 2% , Eye Drop Moxifloxacin 0.5% W/V Ophthalmic Solution Ip 5Ml Size, Tab Cabergoline Ip 0.5Mg Each Uncoated Coated Tablet Contains Cabergoline Ip 0.5Mg, Tab. Levosulpiride 25 Mg Each Uncoated Tablet Contains Levosulpiride 25 Mg, Tab. Dutasteride 0.5 Mg, Inj. Liposomol Amphotericine B 50 Mg, Rabbit-Atg Anti Thymocyte Globulin 25Mg / 5Ml Inj. , Alpelisib 150 Mg Tab. , Glycopegylated Extended Half Life Factor Viii 1000 Iu
